News/ News/ R&D Novel drug to tackle inflammatory diseases begins trial Joy Persaud Bruton Tyrosine Kinase (BTK) inhibitor, fda, inflammatory diseases, Inmagene 0 Comment An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the Share X Novel drug to tackle inflammatory diseases begins trial https://pharmaphorum.com/news/novel-drug-to-tackle-inflammatory-diseases-begins-trial/
News/ News/ R&D Chi-Med agrees R&D partnership with Inmagene Richard Staines Chi-Med, Inmagene, Oncology, R&D 0 Comment China’s Chi-Med and Inmagene Biopharmaceuticals have agreed a strategic partnership to develop preclinical drug candidates for potential treatment Share X Chi-Med agrees R&D partnership with Inmagene https://pharmaphorum.com/news/chi-med-agrees-rd-partnership-with-inmagene/
Bruton Tyrosine Kinase (BTK) inhibitor, fda, inflammatory diseases, Inmagene
0 Comment
